Piribedil

Source: Wikipedia, the free encyclopedia.

Piribedil
Clinical data
AHFS/Drugs.comInternational Drug Names
Routes of
administration
By mouth
ATC code
Legal status
Legal status
  • EU: Rx-only[1]
  • In general: ℞ (Prescription only)
Pharmacokinetic data
Bioavailability10% (peak at 1 hour)
Protein binding70–80%
Metabolismextensive liver
Elimination half-life1.7–6.9 hours
ExcretionKidney (68%) and bile duct (25%)
Identifiers
  • 2-[4-(benzo[1,3]dioxol-5-ylmethyl)piperazin-1-yl]pyrimidine
JSmol)
  • C1CN(CCN1CC2=CC3=C(C=C2)OCO3)C4=NC=CC=N4
  • InChI=1S/C16H18N4O2/c1-4-17-16(18-5-1)20-8-6-19(7-9-20)11-13-2-3-14-15(10-13)22-12-21-14/h1-5,10H,6-9,11-12H2 ☒N
  • Key:OQDPVLVUJFGPGQ-UHFFFAOYSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

Piribedil (trade names Pronoran, Trivastal Retard, Trastal, Trivastan, Clarium and others) is an

α2-adrenergic antagonist properties.[2][3]

Medical uses

Other uses

The drug has been shown to enhance working memory capacities in normal aging adults.[4]

In age-related memory impairment, it has a positive effect on psychophysiological state of elderly people, improving memory and attention and increasing the velocity of psychomotor reactions and lability of nervous processes.[5]

It enhances cognitive skill learning in healthy older adults.[6]

It showed a positive effect in restless legs syndrome.[7]

Side effects

As with other dopamine agonists (like

excessive shopping, increased libido, sexual and/or other intense urges, may develop.[8][9]

Another rare side effect of piribedil is excessive daytime sleepiness and unintended sleep episodes.[9][10]

Overdose

At very high doses, piribedil has an emetic action on the chemoreceptor trigger zone (CTZ). Tablets will thus be rapidly rejected, which explains why no data are currently available concerning the risk of overdosage.[medical citation needed]

Interactions

Dopamine antagonists reduce the effect of piribedil.[medical citation needed]

Pharmacology

Pharmacodynamics

References

  1. ^ "Active substance: piribedil" (PDF). List of nationally authorised medicinal products. European Medicines Agency. 26 November 2020.
  2. PMID 11356907
    .
  3. .
  4. .
  5. .
  6. .
  7. .
  8. .
  9. ^ a b TRIVASTAL Retard 50 (piribedil) Prescribing Information, Servier Laboratories, April 2008. [1] Archived 19 December 2012 at the Wayback Machine
  10. S2CID 22169346
    .
  11. .
  12. .
  13. .
  14. ^ a b Schubert-Zsilavecz M. "Piribedil". Neue Arzneimittel 2008 (in German).